دورية أكاديمية

Chronological changes of the amplitude-integrated EEG in a neonate with molybdenum cofactor deficiency.

التفاصيل البيبلوغرافية
العنوان: Chronological changes of the amplitude-integrated EEG in a neonate with molybdenum cofactor deficiency.
المؤلفون: Sie SD; Department of Neonatology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. s.sie@vumc.nl, de Jonge RC, Blom HJ, Mulder MF, Reiss J, Vermeulen RJ, Peeters-Scholte CM
المصدر: Journal of inherited metabolic disease [J Inherit Metab Dis] 2010 Dec; Vol. 33 Suppl 3, pp. S401-7. Date of Electronic Publication: 2010 Sep 24.
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 7910918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2665 (Electronic) Linking ISSN: 01418955 NLM ISO Abbreviation: J Inherit Metab Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: 2019- : [Hoboken, NJ] : Wiley
Original Publication: [Lancaster, Eng.] MTP Press.
مواضيع طبية MeSH: Brain Waves*/drug effects , Electroencephalography*, Brain/*physiopathology , Coenzymes/*deficiency , Epilepsy/*diagnosis , Metal Metabolism, Inborn Errors/*diagnosis , Metalloproteins/*deficiency, Anticonvulsants/therapeutic use ; Brain/drug effects ; Brain/enzymology ; Coenzymes/genetics ; Diffusion Magnetic Resonance Imaging ; Epilepsy/drug therapy ; Epilepsy/enzymology ; Epilepsy/physiopathology ; Humans ; Infant, Newborn ; Male ; Metal Metabolism, Inborn Errors/enzymology ; Metal Metabolism, Inborn Errors/genetics ; Metal Metabolism, Inborn Errors/physiopathology ; Metalloproteins/genetics ; Molybdenum Cofactors ; Molybdoferredoxin/genetics ; Predictive Value of Tests ; Pteridines ; Sulfites/metabolism ; Time Factors ; Treatment Outcome
مستخلص: Molybdenum cofactor (Moco) deficiency is a rare neurometabolic disorder, characterized by neurological impairment and refractive seizures, due to toxic accumulation of sulfite in the brain. Earlier it was suggested that in Moco-deficient humans maternal clearance of neurotoxic metabolites prevents prenatal brain damage. However, limited data are available about the time profile in which neurophysiologic deterioration occurs after birth. The amplitude-integrated electroencephalography (aEEG) is a bedside method in neonates to monitor cerebral recovery after hypoxic-ischemic insults, detect epileptic activity, and evaluate antiepileptic drug treatment. We describe a chronological series of changes in aEEG tracings in a neonate with Moco deficiency. He presented with myoclonic spasms and hypertonicity a few hours after birth, however, the aEEG pattern was still normal. Within 2 days, the aEEG rapidly changed into a burst suppression pattern with repetitive seizures. After antiepileptic treatment, the aEEG remained abnormal. In this patient, the normal aEEG pattern at birth may have been due to maternal clearance of sulfite in utero. After birth, accumulation of sulfite causes progressive brain damage, reflected by the progressive depression of the aEEG tracings. This is in agreement with the results from a Moco-deficient mouse model, suggesting that maternal sulfite clearance suppresses prenatal brain damage. To our knowledge, this is the first case report describing the chronological changes in the aEEG pattern in a Moco-deficient patient. Insight into the time profile in which neurologic deterioration in Moco-deficient humans occurs is essential, especially when potential treatment strategies are being evaluated.
References: Pediatrics. 2010 May;125(5):e1249-54. (PMID: 20385644)
Semin Fetal Neonatal Med. 2006 Dec;11(6):503-11. (PMID: 17067863)
Prenat Diagn. 2003 Jan;23(1):6-8. (PMID: 12533804)
Pediatrics. 2002 May;109(5):772-9. (PMID: 11986435)
J Child Neurol. 2005 Feb;20(2):155-7. (PMID: 15794186)
Hum Mutat. 2003 Jun;21(6):569-76. (PMID: 12754701)
Hum Mol Genet. 2004 Jun 15;13(12):1249-55. (PMID: 15115759)
Semin Perinatol. 2010 Feb;34(1):28-38. (PMID: 20109970)
Nature. 2009 Aug 13;460(7257):839-47. (PMID: 19675644)
Mol Genet Metab. 2005 May;85(1):12-20. (PMID: 15862276)
Acta Paediatr. 2004 Sep;93(9):1221-7. (PMID: 15384888)
Pediatr Radiol. 2007 Oct;37(10):1043-6. (PMID: 17704913)
المشرفين على المادة: 0 (Anticonvulsants)
0 (Coenzymes)
0 (Metalloproteins)
0 (Molybdenum Cofactors)
0 (Molybdoferredoxin)
0 (Pteridines)
0 (Sulfites)
ATN6EG42UQ (molybdenum cofactor)
SCR Disease Name: Molybdenum cofactor deficiency
تواريخ الأحداث: Date Created: 20100925 Date Completed: 20140408 Latest Revision: 20211203
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC3757261
DOI: 10.1007/s10545-010-9198-z
PMID: 20865336
قاعدة البيانات: MEDLINE
الوصف
تدمد:1573-2665
DOI:10.1007/s10545-010-9198-z